+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 19Years +
All Genders
ID05413057

Observational Study on the Safety and Effectiveness of Fixed-dose FimasartanAmlodipine or FimasartanAmlodipineHydrochlorothiazide for Essential Hypertension

Led by Boryung Pharmaceutical Co., Ltd · Updated on 2025-09-12

20000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective observational study involving patients with essential hypertension to collect data on the effects and side effects of single-pill combinations containing fimasartanamlodipine or fimasartanamlodipinehydrochlorothiazide. The study aims to evaluate blood pressure control and safety over a 12-week period and to follow up those who consent for about 2 years to assess major cardiovascular events and long-term blood pressure management. This study is non-interventional and will be conducted at approximately 600 medical institutions. Treatment decisions, including choice of antihypertensive drugs and duration, are made by investigators based on usual clinical practice. Data collection includes demographic information, disease history, physical measurements, blood pressure values, drug use, adverse reactions, cardiovascular events, and mortality information during long-term follow-up. Participants will be monitored through regular assessments of blood pressure and vital signs, medication use, and adverse events. The main outcome is blood pressure control at 12 weeks, with additional measures at 8, 36, 48, and 96 weeks, including central blood pressure changes and incidence of major cardiovascular events. The study will continue to follow participants for up to 2 years to evaluate long-term safety and effectiveness.

CONDITIONS

Brief Title

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Research Team

M

MyungSook Hong

J

JiYeon Kim

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here